Cardiovascular Events, Sleep Apnoea, and Pulmonary Hypertension in Primary Sjögren’s Syndrome: Data from the French Health Insurance Database

Journal of Clinical Medicine

Nicolas Malafaye¹  Radjiv Goulabchand²  Erik Arnaud²  Benoit Lattuca³  Arnaud Bourdin³  Jacques Morel³  Pierre Fesler³  Camille Roubille³  Thibault Mura³  Lucie Barateau³  Philippe Guilpain³  David Montani⁴ 

[1] Department of Medical Information, Montpellier University Hospital, 34295 Montpellier, France;Internal Medicine Department, CHU Nîmes, University Montpellier, 30029 Nîmes, France;Montpellier School of Medicine, University of Montpellier, 34000 Montpellier, France;Service de Pneumologie et Soins Intensifs Respiratoires, INSERM UMR_S 999, Hôpital Bicêtre, Université Paris-Saclay, 94270 Le Kremlin-Bicêtre, France;

关键词: Sjögren’s syndrome;    cardiovascular diseases;    ischemic heart diseases;    sleep apnoea syndrome;    venous thromboembolic events;    pulmonary hypertension;   

DOI  :  10.3390/jcm10215115

来源: DOAJ

【 摘 要 】

Primary Sjögren’s syndrome (pSS) is an autoimmune disease, associated with a high risk of lymphoma. Mounting evidence suggests that cardiovascular morbidity and mortality are higher in patients with pSS, although data are heterogeneous. The aim of this study was to assess whether pSS patients are at higher risk of hospitalisation for cardiovascular events (CVEs), venous thromboembolic events (VTEs), pulmonary hypertension (PH), and sleep apnoea syndrome (SAS). Through a nationwide population-based retrospective study using the French health insurance database, we selected new-onset pSS in-patients hospitalised between 2011 and 2018. We compared the incidence of CVEs (ischemic heart diseases (IHDs), strokes, and heart failure), SAS, VTEs, and PH with an age- and sex-matched (1:10) hospitalised control group. The calculations of adjusted hazard ratios (aHR) included available confounding factors. We studied 25,661 patients hospitalised for pSS compared with 252,543 matched patients. The incidence of hospitalisation for IHD, SAS, and PH was significantly higher in pSS patients (aHR: 1.20 (1.06–1.34); p = 0.003, aHR: 1.97 (1.70–2.28); p < 0.001, and aHR: 3.32 (2.10–5.25); p < 0.001, respectively), whereas the incidence of stroke, heart failure, and VTE was the same between groups. Further prospective studies are needed to confirm these results and to explore the pathophysiological mechanisms involved.

【 授权许可】

Unknown